Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06928545 · ClinicalTrials.gov registry record
MagDI U.S. Registry
A clinical trial of Internal Hernia and Anastomosis, Surgical, sponsored by GT Metabolic Solutions.
- Recruiting
- Registry status
- 106
- Enrollment target
- 5
- Study locations
NCT06928545: Recruiting study of Internal Hernia and Anastomosis, Surgical, sponsored by GT Metabolic Solutions.
NCT06928545 is a study of Internal Hernia and Anastomosis, Surgical that is actively recruiting participants, run by GT Metabolic Solutions. The registered enrollment target is 106 participants. The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06928545, a study of Internal Hernia and Anastomosis, Surgical, is actively recruiting participants, sponsored by GT Metabolic Solutions.
- RECRUITING
- Registry status
- 106 participants
- Enrollment target
- 5
- Study locations
Study Summary
Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to-side duodeno-ileal anastomoses.
Primary Outcome
To assess and characterize incidence and severity of internal hernia and bowel obstruction at one year in U.S. patients treated with the MagDI System compared with the pre-market study (GTM-001) and scientific literature.
Conditions Studied
Interventions
- DEVICE Side-to-side duodenal-ileal anastomosis
Study Locations (5)
California
- Ventura Advanced Surgical Associates - Ventura
Kentucky
- Baptist Healthcare System, Inc. - Louisville
Louisiana
- Ochsner Clinic Foundation - Lafayette
North Carolina
- Bariatric Specialists of the Carolinas - Cary
Washington
- Transform Weight Loss - Lynnwood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2025-03-28 |
| Est. Completion | 2027-04 |
What NCT06928545 shows while recruiting
NCT06928545 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Internal Hernia appearing as the primary indexed condition, and to 1 intervention - of which Side-to-side duodenal-ileal anastomosis is the first listed.
NCT06928545 lists 5 locations in 5 states (California, Kentucky, Louisiana).
Frequently Asked Questions
What is clinical trial NCT06928545 about?
NCT06928545 is a clinical study titled "MagDI U.S. Registry". Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to-side duodeno-ileal anastomoses.
What is the current status of trial NCT06928545?
This trial is currently recruiting. The enrollment target is 106 participants. The study started on 2025-03-28. Estimated completion is 2027-04.
What conditions does trial NCT06928545 study?
This clinical trial studies the following conditions: Internal Hernia, Anastomosis, Surgical, Bowel Obstruction.
What interventions are being tested in trial NCT06928545?
The interventions under investigation include: Side-to-side duodenal-ileal anastomosis (DEVICE).
Who is sponsoring clinical trial NCT06928545?
This trial is sponsored by GT Metabolic Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06928545 being conducted?
This trial has 5 study locations across California, Kentucky, Louisiana, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Internal Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI